Efficacy and Tolerability of the Association of Sibutramine and Orlistat for Six Months in Overweight and Obese Patients

Objective. To assess the efficacy and tolerability of the association sibutramine (10–20 mg/day) and orlistat (120 mg 2-3 times a day) in the treatment of obesity in a six-month open trial. Methods. 446 overweight and obese patients who sought treatment for obesity in a private clinic were assessed...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Halpern, Alfredo, Pepe, Renata B., Monegaglia, Ana Paola, Beyruti, Mônica, de Melo, Maria Edna, Mancini, Marcio C.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2010
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2943097/
https://ncbi.nlm.nih.gov/pubmed/20871858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/602537
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados